Navigation Links
AAHC Examines Nation's Clinical Trials Infrastructure
Date:10/23/2007

Report Highlights Improvements, Blueprint for Future

WASHINGTON, Oct. 23 /PRNewswire-USNewswire/ -- The Clinical Trials Landscape: Limitations, Strengths, and Promise, the latest report from the Association of Academic Health Centers (AAHC), provides an overview of the infrastructure for clinical trials in the U.S. and a blueprint for action to improve and enhance clinical trials administration in academic health centers nationwide. The infrastructure for clinical trials in the U.S. -- a rarely studied, yet vital, aspect of the U.S. research enterprise -- is examined in new and different ways in this ground-breaking report. Clinical trials are a critical aspect of America's preeminence in science worldwide as they facilitate discoveries to treat and cure illness and disease and improve the quality of life for countless people.

Based on the observations of organization and governance structures at academic health centers, the report assesses the stresses and challenges, delineates impediments to progress, and suggests agents of change that are the strategic imperatives for leaders to improve and enhance research, clinical trials, and compliance operations.

Key to improvement and change is an innovative "functional process map," which describes and organizes the myriad of activities that span clinical trials administration. "This is a powerful tool for academic health centers to assess and evaluate institutional priorities as they analyze the strength of institutional resources along with personnel capabilities and needs. Academic health center leaders will find it useful to consider this roadmap as they move forward with their clinical trials program," says AAHC president and CEO Dr. Steven Wartman. The map is also critical for ultimately developing IT solutions, where they currently do not exist.

"Clinical trials administration and oversight requires the fullest attention of academic health center leaders and this report focuses on
'/>"/>

SOURCE Association of Academic Health Centers
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2008)...ed study will enroll newly diagnosed, elderly AML ...wswire/ -- Celator Pharmaceuticals today announced...omized Phase 2 clinical study of CPX-351 (Cytarabi...th newly diagnosed acute myeloid leukemia (AML). ,...eldman, MD at the Weill Medical College of Cornel...
(Date:11/13/2008)...Study Suggests Nutritional Supplements Prior to Su...re-USNewswire/ -- Identifying,malnutrition before ...dy,contouring will significantly decrease surgical...scar quality and boost patient energy levels,acco...and Reconstructive,Surgery(R), the official medica...
(Date:11/12/2008)...YORK, Nov. 12 A new stu... of Cell will help answer the,question, what cause...questions in the medical research into,Parkinson,s... brain to die,in the first place. Answering this q...e are two nearly identical types of brain cells th...
(Date:11/12/2008)...ELAND, Ohio and LOD, Israel, November 12 /PRNewswi...ical Center, NY indicated that,patient-specific CT...or,(ANGIO Mentor(TM), Simbionix US) with high face... simulation improved the operative flow,increased...decreased,overall operative and fluoroscopy time a...
Breaking Medicine Technology:Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 3Plastic Surgeons Warn of Malnutrition in Body Contouring Patients 2A Window Into Parkinson's Disease 2Vascular Surgeons Agree: Case Rehearsal Improves Outcomes 2Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate 4902 1Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate 4902 2Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate 4902 3Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate 4902 4Cynosure Introduces Smartlipo MPX 28TM 29 Dual Wavelength Workstation for LaserBodySculpting 28SM 29 4900 1Cynosure Introduces Smartlipo MPX 28TM 29 Dual Wavelength Workstation for LaserBodySculpting 28SM 29 4900 2Cynosure Introduces Smartlipo MPX 28TM 29 Dual Wavelength Workstation for LaserBodySculpting 28SM 29 4900 3Cynosure Introduces Smartlipo MPX 28TM 29 Dual Wavelength Workstation for LaserBodySculpting 28SM 29 4900 4Cynosure Introduces Smartlipo MPX 28TM 29 Dual Wavelength Workstation for LaserBodySculpting 28SM 29 4900 5Alfacell Announces Retirement of Chief Executive Officer 4898 1Alfacell Announces Retirement of Chief Executive Officer 4898 2Alfacell Announces Retirement of Chief Executive Officer 4898 3Alfacell Announces Retirement of Chief Executive Officer 4898 4Neuralstem Announces Issuance of Core Technology Patent in Europe 1912 1Neuralstem Announces Issuance of Core Technology Patent in Europe 1912 2
...ans 350,000 Locations Across the Genome From 242,P...te to Acute,Lymphoblastic Leukemia, Suggesting New...ch 07, 2007 /PRNewswire/ -- Investigators at,St. J...reviously,unsuspected mutations that contribute to...ukemia (ALL), the most common cancer in,children. ...
... PARK, N.C., Mar 8, 2007 (CCNMatthews via COMTEX,N...)(AMEX:ADH), a,biopharmaceutical company with a br...nt, today announced that Dr. Antonella,Perotti, MD...dation, an investigator in Adherex,s European Phas...data today from that study at,the 5th Internationa...
Other Medicine Technology:Major Gene Study Uncovers Secrets of Leukemia 2Major Gene Study Uncovers Secrets of Leukemia 3Data From Adherex's European Phase Ib/II Trial of ADH-1 to be,Presented at International Symposium on Targeted Anticancer,Therapies 2Data From Adherex's European Phase Ib/II Trial of ADH-1 to be,Presented at International Symposium on Targeted Anticancer,Therapies 3
(Date:11/21/2008)... 11.4% Shareholders Intend To Vigorously Protect ... CINCINNATI, Nov. 21 D...ay filed an amendment to their Schedule 13D with t...roup previously filed a 13D disclosing ownership o...ch operates 77 LasikPlus fixed-site laser vision c...
(Date:11/21/2008)... NEW YORK, Nov. 21 The general me...voted to induct three new individuals at their Ann... the Pierre hotel in New York. A,Lifetime Achieve...nductees into the Medical Advertising Hall of Fame...ing career with an account position,at Sudler &am...
(Date:11/21/2008)... MONTVALE, N.J., Nov. 21 /PRNewswire-FirstCall/ -...announced that its shareholders overwhelmingly app...the acquisition of Barr by Teva Pharmaceuticals In...y,s vote demonstrated the overwhelming support of ...uce L. Downey, Barr,s Chairman and CEO. "We are pl...
(Date:11/21/2008)... Experiments in mice find running increases produ...ov. 21 (HealthDay News) -- In experiments in mice,...oduction of brain stem cells usually seen with agi...able restoration of the brain,s ability to stave o...o restore a neurochemical that is essential for th...
Breaking Medicine News(10 mins):Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4Health News:Exercise Keeps the Brain Young 2
...rs of the Holocaust are more likely to suffer from...ne Raviv and his colleagues at Israel's //Haifa Un...ed by the near-starvation of European Jews during ...ers looked at the incidence and death rate from ca...
...tors in Toronto are desperately trying to reattach... his foot in a freak accident that involved his fa...g to York Region police the boys father had been r...p unexpectedly behind him. Constable Laurie Perks ...
... University researchers plan to ask women to donat...ryonic stem cells matched to patients // which the... debilitating diseases such as diabates or neurode...ract embryonic stem (ES) cells after creating huma...
...research has revealed that taking antibiotics for ...to 10 days is equally effective in the treatment o...this could also help to curb the rising problem of...ria, Lead researcher Dr. Jan M Prins, an internis...
Other Medicine News:Health News:Pneumonia Effectively Treated with Short-Term Antibiotic Course 2
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
Medicine Products: